France’s Pricing Decisions Portend Private Payment For Pacemakers, ICDs
This article was originally published in The Gray Sheet
Executive Summary
Pricing determinations for implantable cardioverter defibrillators are awaiting a decision from France's Health Minister, following a favorable reimbursement evaluation by the country's lead pricing committee, according to a French device official
You may also be interested in...
French Decree Brings Private Sector Reimbursement System Into View
The recently instituted Evaluation Commission to handle medical device applications for French private hospital reimbursement is expected to begin reviewing manufacturer dossiers in June.
French Health Reform Bill Likely To Contain Device Private Payment Provision
A health care reform proposal to be introduced in France sometime this spring likely will serve as the legislative vehicle for a measure aimed at facilitating private-hospital reimbursement of implantable cardioverter defibrillators, industry reps report.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.